Alternative sequences of thyrotropin and free thyroxine assays for routine thyroid function testing

Archives of Internal Medicine

Volumn 158, Issue 3, 1998, Pages 266-272

  Nordyke, Robert A ^a,b   Reppun, Thomas S ^c   Madanay, Lynn D ^a,b,g   Woods, Joseph C ^d   Goldstern, Alan P ^e   Miyamoto, Linda A ^a,f  

^a STRAUB CLINIC AND HOSPITAL   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c Diagnostic Laboratory Services Inc   (United States)

^d Tripler Army Medical Center

^e KAISER PERMANENTE   (United States)

^f PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN; THYROXINE;

ARTICLE; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HOSPITAL CARE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MEDICARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REIMBURSEMENT; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

HUMANS; MEDICARE; QUALITY OF HEALTH CARE; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; UNITED STATES;

EID: 0032498575     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.3.266     Document Type: Article

References (56)

1. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of laboratory test in thyroid disorders. JAMA. 1990; 263:1529-1532.
2. Spencer CA, LoPresti JS, Van Middlesworth L, et al. Screening for thyroid dysfunction: which test is best? JAMA. 1993;270:2297.
3. Helfand M, Crapo LM. Testing for suspected thyroid disease. In. Sox HC, Huth EJ, eds. Common Diagnostic Tests. 2nd ed. Philadelphia, Pa: American College of Physicians; 1990:148-182.
4. Helfand M, Schmittner J. Screening for thyroid dysfunction: which test is best? JAMA. 1993;270:2297-2298.
5. American Association of Clinical Endocrinologists, American College of Endocrinology. AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract. 1995;1:56-62.
6. Glenn GC and the Laboratory Testing Strategy Task Force of the College of American Pathologists. Practice parameter on laboratory panel testing for screening and case finding in asymptomatic adults. Arch Pathol Lab Med. 1996;120:929-943.
7. Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med. 1990;112: 840-849.
8. Beck RJ. Laboratory decision science applied to chemometrics: strategic testing of thyroid function. Clin Chem. 1986;32:1707-1713.
9. Nolan JP, Tarsa NJ, DiBenedetto G. Case-finding for unsuspected thyroid disease: costs and health benefits. Am J Clin Pathol. 1985;83:346-355.
10. Goldstein BJ, Mushlin AI. Use of a single thyroxine test to evaluate ambulatory medical patients for suspected hypothyroidism. J Gen Intern Med. 1987;2:20-24.
11. Kaye TB. Thyroid function tests: application of newer methods. Postgrad Med. 1993;94:81-90.
12. Christensen RH, Duh SH, Clarisse DE, Zorn N. Thyroid function testing evaluated on three immunoassay systems. J Clin Lab Anal. 1995;9:178-183.
13. Chan DW. Automation of thyroid function testing. Clin Lab Med. 1993;13:631-644.
14. 4 radioimmunoassay. J Clin Immunoassay. 1987;10:50-54.
15. Hershman JM, Pekary AE, Smith VP. Evaluation of five high-sensitivity American thyrotropin assays. Mayo Clin Proc. 1988;63:1131-1139.
16. IMS America, Market Diagnostics. Diagnostic Market Audit, Immunochemistry, 1993 (second report). Plymouth Meeting, Pa: IMS America; 1993.
17. Detsky AS, Naglie IG. A clinician's guide to cost-effectiveness analysis. Ann Intern Med. 1990;113:147-154.
18. Bayer M. Recent developments and most effective laboratory tests for assessment of thyroid status. Med Clin North Am. 1991;75:1-25.
19. de Ios Santos ET, Starich GH, Mazzaferri EL. Sensitivity, specificity, and costeffectiveness of the sensitive thyrotropin assay in the diagnosis of thyroid disease in ambulatory patients. Arch Intern Med. 1989;149:526-532.
20. Schectman JM, Pawlson GL. The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care setting. J Gen Intern Med. 1990;5:9-15.
21. Becker DV, Bigos ST, Gaitan E, et al. Optimal use of blood tests for assessment of thyroid function. JAMA. 1993;269:2736-2737.
22. Danese MD, Powe NR, Sawin CT, Ladenson PW. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA. 1996;276:285-292.
23. Davey RX, Clarke MI, Webster AR. Thyroid function testing based on assay of thyroid-stimulating hormone: assessing an algorithm's reliability. Med J Aust. 1996;164:329-332.
24. Feldkamp CS, Carey JI. An algorithmic approach to thyroid function testing in a managed care setting: 3-year experience. Am J Clin Pathol. 1996;105:11-16.
25. Caldwell G, Kellett HA, Gow SM, et al. A new strategy for thyroid function testing. Lancet. 1985;1:1117-1119.
26. John R, Henley R, Lloyd G, Elder GH. Evaluation of a new strategy for detection of thyroid dysfunction in the routine laboratory. Clin Chem. 1988;34:1110-1114.
27. Seth J, Beckett G. Diagnosis of hyperthyroidism: the newer biochemical tests. J Clin Endocrinol Metab. 1985;14:373-396.
28. Ross DS. New sensitive immunoradiometric assays for thyrotropin. Ann Intern Med. 1986;104:718-720.
29. Fraser WD, Biggart EM, O'Reilley DSJ, Gray HW, McKillop JH. Are biochemical tests of thyroid function of any value in monitoring patients receiving thyroxine replacement? BMJ. 1986;293:808-810.
30. Toft AD. Thyroxine replacement treatment: clinical judgment or biochemical control? BMJ. 1985;291:233-234.
31. Samuels MH, Ridgway EC. Central hypothyroidism. Endocrinol Metab Clin North Am. 1992;21:903-919.
32. Stockigt JR. Serum thyrotropin and thyroid hormone measurements and assessment of thyroid hormone transport. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's The Thyroid. 7th ed. Philadelphia, Pa: Lippincott-Raven; 1996:377-396.
33. 131I therapy for thyrotoxicosis. J Clin Endocrinol Metab. 1974;39:607-609.
34. Gomez N, Gomez JM, Orti A, et al. Transient hypothyroidism after iodine-131 therapy for Grave's disease. J Nucl Med. 1995;36:1539-1542.
35. Fish LH, Schwanz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism: role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987;316:764-770.
36. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy in patients with thyroid disease. Ann Intern Med. 1993;119:492-502.
37. Helfand M, Crapo LM. Monitoring therapy in patients taking levothyroxine. Ann Intern Med. 1990;113:450-454.
38. Cooper DS, Halpern R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med. 1984;101:18-24.
39. Staub JJ, Althaus BU, Engler H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med. 1992;92:631-642.
40. Ridgway CE, Cooper DS, Walker H, Rodbard D, Maloof F. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1981;53:1238-1242.
41. Franklyn JA, Daykin J, Betteridge J, et al. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf). 1993;38:453-459.
42. Miura S, Itaka M, Yoshimura H, et al. Disturbed lipid metabolism in patients with subclinical hypothyroidism: effect of L-thyroxine therapy. Intern Med. 1994;33: 413-417.
43. Arem R, Escalante DA, Arem N, Morrisett JD, Patsch W. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a). Metabolism. 1995;44:1559-1563.
44. Tunbridge WM, Brewis M, French JM, et al. Natural hislory of autoimmune thyroiditis. BMJ. 1981;282:258-262.
45. Gordin A, Lamberg BA. Spontaneous hypothyroidism in symptomless autoimmune thyroiditis: a long-term follow-up study. Clin Endocrinol (Oxf). 1981;15: 537-543.
46. Jaeschke R, Guyatt G, Gerstein H, et al. Does treatment with L-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism? J Gen Intern Med. 1996;11:744-749.
47. Biondi B, Fazio S, Carella C, et al. Control of adrenergic overactivity by β-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab. 1994;78:1028-1033.
48. Banovac K, Papic M, Bilsker MS, Zakarija M, McKenzie JM. Evidence of hyperthyroidism in apparently euthyroid patients treated with levothyroxine. Arch Intern Med. 1989;149:809-812.
49. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249-1252.
50. Coindre JM, David JP, Riviere L, et al. Bone loss in hypothyroidism with hormone replacement: a histomorphometric study. Arch Intern Med. 1986;146:48-53.
51. Stall GM, Harris S, Sokoll LJ, Dawson-Hughes B. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med. 1990;113:265-269.
52. Schneider DL, Barrett-Connor EL, Morton DJ. Thyroid hormone use and bone mineral density in elderly women: effects of estrogen. JAMA. 1994;271:1245-1249.
53. Ross DS. Hyperthyroidism, thyroid hormone therapy, and bone. Thyroid. 1994; 19:319-326.
54. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endocrinol Metab. 1994;78:818-823.
55. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC. Prevalence and follow-up of abnormal thyrotropin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf). 1991;34:77-83.
56. Sundbeck G, Jagenburg R, Johansson P-M, Edén S, Lindstedt G. Clinical significance of low serum thyrotropin concentration by chemiluminometric assay in 85-year-old women and men. Arch Intern Med. 1991;151:549-556.